These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 7437223)
21. Secretion of dantrolene into breast milk after acute therapy of a suspected malignant hyperthermia crisis during cesarean section. Fricker RM; Hoerauf KH; Drewe J; Kress HG Anesthesiology; 1998 Oct; 89(4):1023-5. PubMed ID: 9778021 [No Abstract] [Full Text] [Related]
22. Malignant hyperthermia in a young adolescent: A case report. Toh H; Shahani JM; Ali AJ Natl Med J India; 2014; 27(5):259-60. PubMed ID: 26037425 [TBL] [Abstract][Full Text] [Related]
23. [Treatment of malignant hyperthermia with dantrolene]. Landauer B Anaesthesist; 1980 Sep; 29(9):507-8. PubMed ID: 7468992 [No Abstract] [Full Text] [Related]
24. Treatment of malignant hyperthermia with dantrolene. Cooper JM; Jones HR; Williamson JW J Miss State Med Assoc; 1983 Oct; 24(10):259-61. PubMed ID: 6644804 [No Abstract] [Full Text] [Related]
25. Upper extremity deep vein thrombosis in a patient treated for malignant hyperthermia. Grodofsky S; Levitt C; Schlichter RA; Stanton DC; Liu R; Chen L J Clin Anesth; 2013 Jun; 25(4):350-2. PubMed ID: 23707708 [No Abstract] [Full Text] [Related]
30. Dantrolene sodium approved for malignant hyperthermia. FDA Drug Bull; 1979 Nov; 9(5):27. PubMed ID: 510837 [No Abstract] [Full Text] [Related]
31. Malignant hyperthermia. Considerations for the ophthalmologist. Sedwick LA; Romano PE Surv Ophthalmol; 1981; 25(6):378-82. PubMed ID: 7245023 [TBL] [Abstract][Full Text] [Related]
32. [Non-rigid type malignant hyperthermia and dantrolene sodium]. Hayakawa A; Shimonaka H; Uematsu H; Yamamoto M Masui; 1988 Oct; 37(10):1243-8. PubMed ID: 3058994 [No Abstract] [Full Text] [Related]
33. Dantrolene therapy for malignant hyperthermia. Hoff B; Taylor C; Kruel J Crit Care Med; 1980 Nov; 8(11):699-700. PubMed ID: 7428399 [No Abstract] [Full Text] [Related]
34. [An original technic for the preparation of an injectable solution of sodium dantrolene from oral capsules (Dantralen) or from the pure substance]. de Pascual Mettler I; Borrego Dionis AM; González Machado JL Rev Esp Anestesiol Reanim; 1985; 32(4):166-8. PubMed ID: 4048581 [No Abstract] [Full Text] [Related]
35. Malignant hyperthermia in a liver transplant patient: a case report. Fernandes CR; Azevedo DM; Gomes JM; Gonçalves BP; Coelho GR; Vasconcelos JB; Garcia JH Transplant Proc; 2007 Dec; 39(10):3530-2. PubMed ID: 18089429 [TBL] [Abstract][Full Text] [Related]
37. Dantrolene in malignant hyperthermia (MH)-susceptible patients with exaggerated exercise stress. Gronert GA Anesthesiology; 2000 Sep; 93(3):905. PubMed ID: 10969335 [No Abstract] [Full Text] [Related]
38. Malignant hyperthermia. A review and case report. Haber J; Hammer DJ; Butler B J Am Podiatry Assoc; 1983 Aug; 73(8):422-6. PubMed ID: 6619495 [No Abstract] [Full Text] [Related]
39. Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs. Schütte JK; Becker S; Burmester S; Starosse A; Lenz D; Kröner L; Wappler F; Gerbershagen MU Eur J Anaesthesiol; 2011 Apr; 28(4):256-64. PubMed ID: 21513076 [TBL] [Abstract][Full Text] [Related]